youtube_live
Q3 2026 daromadi • nashr etilgan • Aksiya boʻyicha daromad kutilganidan yuqori +11,45% • Daromad kutilganidan yuqori +3,01%
Natijalarini ochishchevron_right
AMG:ETR
Amgen
418,15 €
arrow_downward
-1,26%(-5,35) 1K
5-noy, 17:35:54 (GMT+1) · EUR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoAMG tikeri uchun statistika yaratilmoqda...
Ochish
423,95 €
Yuqori
431,20 €
Past
418,15 €
Bozor kapitali
249,01 mlrd
Oʻrtacha hajm
510,00
Hajmi
671,00
52 haftalik eng yuqori
438,75 €
52 haftalik eng past
263,60 €
Xodimlar soni
32 ming
Ochish
423,95 €
Yuqori
431,20 €
Past
418,15 €
Bozor kapitali
249,01 mlrd
Oʻrtacha hajm
510,00
Hajmi
671,00
52 haftalik eng yuqori
438,75 €
52 haftalik eng past
263,60 €
Xodimlar soni
32 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
GuruFocus
·
5 soat oldin
Amgen Inc (AMGN) Shares Fall 3.8% -- GF Value Says Still Overval
MarketWatch
·
7 soat oldin
Amgen Inc. stock underperforms Thursday when compared to competitors
Trefis
·
11 soat oldin
What Are Amgen Investors Betting On?
The Motley Fool
·
12 soat oldin
Amgen vs. Pfizer: Which Healthcare Stock Is a Better Buy for 2027?
Profil
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Amgen haqida
CEORobert A. Bradway
Xodimlar soni31,5 ming
Asos solingan1980
Bosh ofislarTauzand-Oks, Kaliforniya, Amerika Qo‘shma Shtatlari
SektorHealth Care
Industry-
Veb-saytamgen.com